Menu
GeneBe

SAE1

SUMO1 activating enzyme subunit 1, the group of Ubiquitin like modifier activating enzymes

Basic information

Region (hg38): 19:47113273-47210636

Links

ENSG00000142230NCBI:10055OMIM:613294HGNC:30660Uniprot:Q9UBE0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SAE1 gene.

  • Inborn genetic diseases (7 variants)
  • not provided (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SAE1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
7
clinvar
1
clinvar
8
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 7 2 1

Variants in SAE1

This is a list of pathogenic ClinVar variants found in the SAE1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-47130961-A-G not specified Uncertain significance (Aug 18, 2023)2599679
19-47131010-G-A not specified Uncertain significance (Mar 21, 2022)2279179
19-47143522-G-A Likely benign (Apr 01, 2022)2650142
19-47143562-T-G not specified Uncertain significance (Oct 03, 2023)3157487
19-47150242-C-A not specified Uncertain significance (Sep 17, 2021)2261414
19-47150257-G-A not specified Uncertain significance (Mar 22, 2023)2508693
19-47150262-A-G not specified Uncertain significance (Mar 01, 2024)3157488
19-47150323-A-G not specified Uncertain significance (Dec 13, 2023)3157489
19-47150340-A-G not specified Uncertain significance (Nov 08, 2022)2386544
19-47197285-T-C Benign (Dec 31, 2019)778848
19-47197298-G-C not specified Uncertain significance (Jan 08, 2024)3157490
19-47203687-A-G not specified Uncertain significance (Feb 14, 2024)3157491
19-47203732-A-G not specified Uncertain significance (Dec 08, 2023)3157492
19-47209190-A-G not specified Uncertain significance (Aug 02, 2021)2240460
19-47209207-G-A not specified Uncertain significance (Apr 07, 2023)2534982
19-47209278-G-A Likely benign (Apr 01, 2022)2650143

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SAE1protein_codingprotein_codingENST00000270225 997356
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9880.01241257350111257460.0000437
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5631701920.8860.00001012267
Missense in Polyphen3856.5380.67212687
Synonymous-0.4787771.81.070.00000397664
Loss of Function3.67117.70.05669.29e-7215

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00003330.0000333
Ashkenazi Jewish0.0001980.000198
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000008800.00000879
Middle Eastern0.000.00
South Asian0.0001960.000196
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: The heterodimer acts as an E1 ligase for SUMO1, SUMO2, SUMO3, and probably SUMO4. It mediates ATP-dependent activation of SUMO proteins followed by formation of a thioester bond between a SUMO protein and a conserved active site cysteine residue on UBA2/SAE2. {ECO:0000269|PubMed:10187858, ECO:0000269|PubMed:10217437, ECO:0000269|PubMed:11451954, ECO:0000269|PubMed:11481243, ECO:0000269|PubMed:15660128, ECO:0000269|PubMed:20164921, ECO:0000269|PubMed:9920803}.;
Pathway
Ubiquitin mediated proteolysis - Homo sapiens (human);er associated degradation (erad) pathway;SUMO is conjugated to E1 (UBA2:SAE1);SUMO is transferred from E1 to E2 (UBE2I, UBC9);Post-translational protein modification;basic mechanisms of sumoylation;Metabolism of proteins;Processing and activation of SUMO;SUMOylation (Consensus)

Recessive Scores

pRec
0.125

Intolerance Scores

loftool
0.449
rvis_EVS
-0.38
rvis_percentile_EVS
27.88

Haploinsufficiency Scores

pHI
0.632
hipred
Y
hipred_score
0.831
ghis
0.662

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.997

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sae1
Phenotype

Zebrafish Information Network

Gene name
sae1
Affected structure
hematopoietic multipotent progenitor cell
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
protein ubiquitination;protein sumoylation;protein modification by small protein conjugation;positive regulation of catalytic activity;positive regulation of protein targeting to mitochondrion
Cellular component
nucleus;nucleoplasm;cytoplasm;SUMO activating enzyme complex
Molecular function
ubiquitin activating enzyme activity;protein binding;protein C-terminus binding;enzyme activator activity;SUMO activating enzyme activity;ATP-dependent protein binding;small protein activating enzyme binding;protein heterodimerization activity